Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2021 1
2022 1
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Combination therapy with topotecan, paclitaxel, and bevacizumab improves progression-free survival in patients with recurrent high-grade neuroendocrine cervical cancer: a Neuroendocrine Cervical Tumor Registry (NeCTuR) study.
Frumovitz M, Chisholm GB, Jhingran A, Ramalingam P, Flores-Legarreta A, Bhosale P, Gonzales NR, Hillman RT, Salvo G. Frumovitz M, et al. Among authors: flores legarreta a. Am J Obstet Gynecol. 2023 Apr;228(4):445.e1-445.e8. doi: 10.1016/j.ajog.2022.12.009. Epub 2022 Dec 11. Am J Obstet Gynecol. 2023. PMID: 36516952
Neuroendocrine neoplasms of the ovary: a review of 63 cases.
Flores Legarreta A, Saab R, Gonzales NR, Chisholm GB, Westin SN, Hillman RT, Frumovitz M. Flores Legarreta A, et al. Int J Gynecol Cancer. 2024 Apr 1;34(4):566-573. doi: 10.1136/ijgc-2023-005063. Int J Gynecol Cancer. 2024. PMID: 38290783 Review.
Impact of pelvic radiation therapy in patients with early neuroendocrine cervical carcinoma and no residual disease in the radical hysterectomy specimen: a NeCTuR study.
Khurana N, Frumovitz M, Flores Legarreta A, Ramalingam P, Jhingran A, Bhosale P, Saab R, Gonzales NRR, Chisholm GB, Salvo G. Khurana N, et al. Among authors: flores legarreta a. Int J Gynecol Cancer. 2023 Dec 14:ijgc-2023-005053. doi: 10.1136/ijgc-2023-005053. Online ahead of print. Int J Gynecol Cancer. 2023. PMID: 38101814